AstraZeneca PLC (AZNCF)
130.24
+1.04
(+0.80%)
USD |
OTCM |
Nov 14, 16:00
AstraZeneca Shareholders Equity (Quarterly): 39.51B for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 39.51B |
| March 31, 2024 | 37.44B |
| December 31, 2023 | 39.14B |
| September 30, 2023 | 37.20B |
| June 30, 2023 | 37.39B |
| March 31, 2023 | 35.79B |
| December 31, 2022 | 37.04B |
| September 30, 2022 | 35.13B |
| June 30, 2022 | 35.93B |
| March 31, 2022 | 36.34B |
| December 31, 2021 | 39.27B |
| September 30, 2021 | 39.74B |
| June 30, 2021 | 15.68B |
| March 31, 2021 | 14.43B |
| December 31, 2020 | 15.62B |
| September 30, 2020 | 12.20B |
| June 30, 2020 | 12.24B |
| March 31, 2020 | 10.78B |
| December 31, 2019 | 13.13B |
| September 30, 2019 | 12.16B |
| June 30, 2019 | 13.55B |
| March 31, 2019 | 10.48B |
| December 31, 2018 | 12.47B |
| September 30, 2018 | 11.94B |
| June 30, 2018 | 12.64B |
| Date | Value |
|---|---|
| March 31, 2018 | 12.92B |
| December 31, 2017 | 14.96B |
| September 30, 2017 | 13.72B |
| June 30, 2017 | 13.65B |
| March 31, 2017 | 12.99B |
| December 31, 2016 | 14.85B |
| September 30, 2016 | 13.07B |
| June 30, 2016 | 13.53B |
| March 31, 2016 | 14.74B |
| December 31, 2015 | 18.49B |
| September 30, 2015 | 17.35B |
| June 30, 2015 | 18.28B |
| March 31, 2015 | 16.94B |
| December 31, 2014 | 19.63B |
| September 30, 2014 | 20.44B |
| June 30, 2014 | 22.03B |
| March 31, 2014 | 21.45B |
| December 31, 2013 | 23.22B |
| September 30, 2013 | 23.25B |
| June 30, 2013 | 23.22B |
| March 31, 2013 | 22.29B |
| December 31, 2012 | 23.73B |
| September 30, 2012 | 22.04B |
| June 30, 2012 | 22.03B |
| March 31, 2012 | 21.52B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
10.78B
Minimum
Mar 2020
39.74B
Maximum
Sep 2021
28.63B
Average
35.93B
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 96.27M |
| Biodexa Pharmaceuticals PLC | 11.04M |
| Verona Pharma PLC | 130.49M |
| NuCana PLC | 4.806M |
| Autolus Therapeutics PLC | 527.84M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 104.34B |
| Total Liabilities (Quarterly) | 64.74B |
| Debt to Equity Ratio | 0.8173 |
| Current Ratio | 0.8889 |
| Net Debt Paydown Yield | -0.14% |